These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27112320)

  • 1. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.
    Jung CH; Kang YM; Jang JE; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Obesity (Silver Spring); 2016 Jun; 24(6):1373-9. PubMed ID: 27112320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation.
    Jung CH; Lee MJ; Kang YM; Jang JE; Leem J; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    J Clin Endocrinol Metab; 2015 Mar; 100(3):934-41. PubMed ID: 25490279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
    Jacobs S; Schiller K; Jansen EH; Boeing H; Schulze MB; Kröger J
    Am J Clin Nutr; 2015 Jul; 102(1):155-64. PubMed ID: 25971719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality.
    Onat A; Can G; Kaya A; Akbaş T; Özpamuk-Karadeniz F; Şimşek B; Çakır H; Yüksel H
    World J Gastroenterol; 2015 Dec; 21(48):13555-65. PubMed ID: 26730168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fatty liver index with risk of incident type 2 diabetes by metabolic syndrome status in an Eastern Finland male cohort: a prospective study.
    Olubamwo OO; Virtanen JK; Pihlajamaki J; Tuomainen TP
    BMJ Open; 2019 Jul; 9(7):e026949. PubMed ID: 31278098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty liver index as a predictor of increased risk of cardiometabolic disease: finding from the Kuopio Ischaemic Heart Disease Risk Factor Study Cohort.
    Olubamwo OO; Virtanen JK; Pihlajamaki J; Mantyselka P; Tuomainen TP
    BMJ Open; 2019 Sep; 9(9):e031420. PubMed ID: 31492793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAT-FREE MASS, METABOLICALLY HEALTHY OBESITY, AND TYPE 2 DIABETES IN SEVERELY OBESE ASIAN ADULTS.
    Pramyothin P; Limpattanachart V; Dawilai S; Sarasak R; Sukaruttanawong C; Chaiyasoot K; Keawtanom S; Yamwong P
    Endocr Pract; 2017 Aug; 23(8):915-922. PubMed ID: 28614006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic status of metabolically healthy overweight/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: A cohort study of a rural adult Chinese population.
    Wang B; Zhang M; Wang S; Wang C; Wang J; Li L; Zhang L; Ren Y; Han C; Zhao Y; Zhou J; Wang G; Shen Y; Wu D; Pang C; Yin L; Feng T; Zhao J; Luo X; Hu D
    Obes Res Clin Pract; 2018; 12(1):61-71. PubMed ID: 29100915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).
    Heianza Y; Arase Y; Tsuji H; Fujihara K; Saito K; Hsieh SD; Tanaka S; Kodama S; Hara S; Sone H
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2952-60. PubMed ID: 24823457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increased liver enzymes and metabolic risk - case 7/2011].
    Dudziak K; Machann J; Schick F; Claussen CD; Wehrmann M; Häring HU; Fritsche A; Stefan N; Müssig K
    Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1476. PubMed ID: 21811970
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolically healthy obesity without fatty liver and risk of incident type 2 diabetes: A meta-analysis of prospective cohort studies.
    Hashimoto Y; Hamaguchi M; Tanaka M; Obora A; Kojima T; Fukui M
    Obes Res Clin Pract; 2018; 12(1):4-15. PubMed ID: 29307656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically healthy obesity was significantly associated with increased risk of gallstones.
    Man S; Gao Y; Lv J; Tong M; Yin J; Wang B; Ning Y; Li L
    Eur J Endocrinol; 2022 Jan; 186(2):275-283. PubMed ID: 34889778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver index, gamma-glutamyltransferase, and early carotid plaques.
    Kozakova M; Palombo C; Eng MP; Dekker J; Flyvbjerg A; Mitrakou A; Gastaldelli A; Ferrannini E;
    Hepatology; 2012 May; 55(5):1406-15. PubMed ID: 22334565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study.
    Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    BMC Endocr Disord; 2020 Jan; 20(1):11. PubMed ID: 31959179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.